Vertex Pharmaceuticals Inc. sell Robert W. Baird
Start price
31.01.24
/
50%
€400.05
Target price
31.01.25
€299.00
Performance (%)
10.29%
End price
01.02.25
€441.20
Summary
This prediction ended on 01.02.25 with a price of €441.20. The prediction closed with a disappointing performance of 10.29%. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.412% | 2.412% | -6.387% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % |
Comments by Robert_W__Baird for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Robert W. Baird from a "neutral" rating to an "underperform" rating. They now have a $325.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat